CASI Pharmaceuticals (CASIF) Return on Sales [ROS] (2022 - 2025)
CASI Pharmaceuticals (CASIF) posted Return on Sales [ROS] of -1068.86% for Q4 2025, down 972.17 percentage points from -96.69% a year earlier and down 721.64 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Return on Sales [ROS] (2022 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals' Return on Sales [ROS] came in at -217.30%, down 78.46 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +131.30 percentage points (FY2020 to FY2025).
- In prior years, CASI Pharmaceuticals' Return on Sales [ROS] was -138.84% in FY2024 (-64.81 pp), -74.03% in FY2023 (+4.92 pp), -78.95% in FY2022 (+58.67 pp) and -137.62% in FY2021 (+210.98 pp).
- The Q4 2025 figure stands as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2022.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -192.60 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2025, with a gain of 110.99 percentage points; the weakest was Q4 2025, with a drop of 972.17 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -347.22% (Q3 2025), -266.47% (Q2 2025) and -166.33% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -177.53% |
| Sep 30, 2025 | -347.22% |
| Jun 30, 2025 | -266.47% |
| Mar 31, 2025 | -166.33% |
| Dec 31, 2024 | -96.69% |
| Sep 30, 2024 | -108.61% |
| Jun 30, 2024 | -220.88% |
| Mar 31, 2024 | -277.32% |
| Dec 31, 2023 | -68.85% |
| Sep 30, 2023 | -57.65% |
| Jun 30, 2023 | -95.16% |
| Mar 31, 2023 | -86.41% |
| Dec 31, 2022 | -98.09% |
| Sep 30, 2022 | -55.98% |
| Jun 30, 2022 | -74.55% |
| Mar 31, 2022 | -76.77% |
API Access
CASI Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();